Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADVM


Fundamental

Company: Adverum Biotechnologies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -6.39
Insider Own: 33.84%
Shs Outstand: 20.89M
Perf Week: -24.73%
Market Cap: 44.18M
Forward P/E: -
EPS next Y: -3.69
Insider Trans: 14.29%
Shs Float: 13.82M
Perf Month: -29.03%
Income: -133.56M
PEG: -
EPS next Q: -2.08
Inst Own: 58.46%
Short Float: 10.73%
Perf Quarter: -52.58%
Sales: 1.00M
P/S: 44.18
EPS this Y: 8.28%
Inst Trans: -13.44%
Short Ratio: 4.47
Perf Half Y: -73.19%
Book/sh: 1.26
P/B: 1.67
EPS next Y Percentage: 39.29%
ROA: -65.88%
Short Interest: 1.48M
Perf Year: -76.32%
Cash/sh: 3.98
P/C: 0.53
EPS next 5Y: 12.12%
ROE: -127.99%
52W Range From: 1.78
52W Range To: 10.14
Perf YTD: -54.71%
Dividend Est.: -
P/FCF: -
EPS past 5Y: 8.03%
ROI: -118.86%
52W High: -79.14%
Beta: 0.68
Dividend TTM: -
Quick Ratio: 3.57
Sales past 5Y: -54.44%
Gross Margin: -233.90%
52W Low: 18.82%
ATR (14): 0.37
Dividend Ex-Date: -
Current Ratio: 3.57
EPS Y/Y TTM: 37.54%
Oper. Margin: -15364.20%
RSI (14): 30.42
Volatility W: 16.45%
Volatility M: 12.19%
Employees: 155
Debt/Eq: 3.53
Sales Y/Y TTM: -72.22%
Profit Margin: -13356.00%
Recom: 1.29
Target Price: 23.00
Option/Short: Yes / Yes
LT Debt/Eq: 3.25
EPS Q/Q: -49.29%
Payout: -
Rel Volume: 1.18
Prev Close: 2.05
Sales Surprise: -
EPS Surprise: -15.98%
Sales Q/Q: -
Earnings: May 14 AMC
Avg Volume: 331.92K
Price: 2.12
SMA20: -26.45%
SMA50: -43.08%
SMA200: -61.70%
Trades:
Volume: 391,743
Change: 3.17%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z